Literature DB >> 10734235

The survival motor neuron protein interacts with the transactivator FUSE binding protein from human fetal brain.

B Y Williams1, S L Hamilton, H K Sarkar.   

Abstract

To identify interacting proteins of survival motor neuron (SMN) in neurons, a fetal human brain cDNA library was screened using the yeast two-hybrid system. One identified group of SMN interacting clones encoded the DNA transactivator FUSE binding protein (FBP). FBP overexpressed in HEK293 cells or endogenously expressed in fetal and adult mouse brain bound specifically in vitro to recombinant SMN protein. Furthermore, an anti-FBP antibody specifically co-immunoprecipitated SMN when both proteins were overexpressed in HEK293 cells. These results demonstrate that FBP is a novel interacting partner of SMN and suggests a possible role for SMN in neuronal gene expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10734235     DOI: 10.1016/s0014-5793(00)01320-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Axonal-SMN (a-SMN), a protein isoform of the survival motor neuron gene, is specifically involved in axonogenesis.

Authors:  Veronica Setola; Mineko Terao; Denise Locatelli; Stefania Bassanini; Enrico Garattini; Giorgio Battaglia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-29       Impact factor: 11.205

Review 2.  Congenital bone fractures in spinal muscular atrophy: functional role for SMN protein in bone remodeling.

Authors:  Srinivasan Shanmugarajan; Kathryn J Swoboda; Susan T Iannaccone; William L Ries; Bernard L Maria; Sakamuri V Reddy
Journal:  J Child Neurol       Date:  2007-08       Impact factor: 1.987

Review 3.  Far upstream element binding protein 1: a commander of transcription, translation and beyond.

Authors:  J Zhang; Q M Chen
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

4.  Spinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexes.

Authors:  Wilfried Rossoll; Gary J Bassell
Journal:  Results Probl Cell Differ       Date:  2009

5.  Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy.

Authors:  Srinivasan Shanmugarajan; Eichi Tsuruga; Kathryn J Swoboda; Bernard L Maria; William L Ries; Sakamuri V Reddy
Journal:  J Pathol       Date:  2009-09       Impact factor: 7.996

Review 6.  The master regulator FUBP1: its emerging role in normal cell function and malignant development.

Authors:  Lydie Debaize; Marie-Bérengère Troadec
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

7.  Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1.

Authors:  Claudia Helmken; Yvonne Hofmann; Frank Schoenen; Gabriela Oprea; Heidrun Raschke; Sabine Rudnik-Schöneborn; Klaus Zerres; Brunhilde Wirth
Journal:  Hum Genet       Date:  2003-10-01       Impact factor: 4.132

8.  Upregulation of Far Upstream Element-Binding Protein 1 (FUBP1) Promotes Tumor Proliferation and Tumorigenesis of Clear Cell Renal Cell Carcinoma.

Authors:  Junyao Duan; Xu Bao; Xin Ma; Yu Zhang; Dong Ni; Hanfeng Wang; Fan Zhang; Qingshan Du; Yang Fan; Jianwen Chen; Shengpan Wu; Xintao Li; Yu Gao; Xu Zhang
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

9.  Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy.

Authors:  Dirk Bäumer; Sheena Lee; George Nicholson; Joanna L Davies; Nicholas J Parkinson; Lyndsay M Murray; Thomas H Gillingwater; Olaf Ansorge; Kay E Davies; Kevin Talbot
Journal:  PLoS Genet       Date:  2009-12-18       Impact factor: 5.917

10.  Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.

Authors:  Sophie Eisenreich; Khalil Abou-El-Ardat; Karol Szafranski; Jaime A Campos Valenzuela; Andreas Rump; Janice M Nigro; Rolf Bjerkvig; Eva-Maria Gerlach; Karl Hackmann; Evelin Schröck; Dietmar Krex; Lars Kaderali; Gabriele Schackert; Matthias Platzer; Barbara Klink
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.